| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | Sep 30, 2024 | Audet Juliette Berangere Chief Business Officer | Buy | Newamsterdam Pharma Co N.V. | NAMS | $15.7 | $17,333 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.